Cross Country Healthcare (CCRN)
(Delayed Data from NSDQ)
$9.81 USD
-0.20 (-2.00%)
Updated Nov 15, 2024 04:00 PM ET
After-Market: $9.79 -0.02 (-0.20%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth D Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$9.81 USD
-0.20 (-2.00%)
Updated Nov 15, 2024 04:00 PM ET
After-Market: $9.79 -0.02 (-0.20%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth D Momentum A VGM
Zacks News
Cross Country (CCRN) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
The headline numbers for Cross Country (CCRN) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Cross Country Healthcare (CCRN) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Cross Country (CCRN) delivered earnings and revenue surprises of 20% and 1.63%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
TrueBlue (TBI) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
TrueBlue (TBI) delivered earnings and revenue surprises of 52.17% and 0.19%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Is the Options Market Predicting a Spike in Cross Country Healthcare (CCRN) Stock?
by Zacks Equity Research
Investors need to pay close attention to Cross Country Healthcare (CCRN) stock based on the movements in the options market lately.
Cross Country (CCRN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Cross Country (CCRN) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Cross Country Healthcare (CCRN) Lags Q2 Earnings Estimates
by Zacks Equity Research
Cross Country (CCRN) delivered earnings and revenue surprises of -28.57% and 1.63%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Do Options Traders Know Something About Cross Country Healthcare (CCRN) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Cross Country Healthcare (CCRN) stock based on the movements in the options market lately.
Compared to Estimates, Cross Country (CCRN) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Cross Country (CCRN) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
New Strong Sell Stocks for February 27th
by Zacks Equity Research
CAR, CCRN and ECPG have been added to the Zacks Rank #5 (Strong Sell) List on February 27, 2023.
5 Stocks Favored by Brokers Amid the Current Uncertainty
by Maharathi Basu
We believe that stocks like Deutsche Bank (DB), Cross Country Healthcare (CCRN), Bread Financial (BFH), American Axle (AXL) and Cardinal Health (CAH) should be on an investor's watchlist.
Cross Country (CCRN) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Cross Country (CCRN) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Curious about Cross Country (CCRN) Q4 Performance? Explore Wall Street Estimates for Key Metrics
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for Cross Country (CCRN), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.
The Zacks Analyst Blog Highlights Cross Country Healthcare, HireQuest, Heidrick & Struggles, KornFerry and TrueBlue
by Zacks Equity Research
Cross Country Healthcare, HireQuest, Heidrick & Struggles, KornFerry and TrueBlue are included in this Analyst Blog.
5 Staffing Stocks to Gain as Labor Market Remains Hot
by Tirthankar Chakraborty
Keep an eye on staffing stocks like Cross Country Healthcare (CCRN), HireQuest (HQI), Heidrick & Struggles International (HSII), KornFerry International (KFY) and TrueBlue (TBI), banking on solid January jobs growth.
Compared to Estimates, Cross Country (CCRN) Q3 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Cross Country (CCRN) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Analysts Estimate Cross Country Healthcare (CCRN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Cross Country (CCRN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for August 7th
by Zacks Equity Research
BANR, COLM and CCRN have been added to the Zacks Rank #5 (Strong Sell) List on August 7, 2023.
Cross Country (CCRN) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Cross Country (CCRN) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Cross Country Healthcare (CCRN) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Cross Country (CCRN) delivered earnings and revenue surprises of 13.11% and 2.06%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Kforce (KFRC) Misses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Kforce (KFRC) delivered earnings and revenue surprises of -3.06% and 1.72%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Cross Country Healthcare (CCRN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Cross Country (CCRN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Boise Cascade and Cross Country Healthcare have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Boise Cascade and Cross Country Healthcare are part of the Zacks Bull and Bear of the Day article.
Bear Of The Day: Cross Country Healthcare (CCRN)
by Brian Bolan
I was shocked to see this stock with the lowest Zacks Rank considering it was a 221% winner for Stocks Under $10.
New Strong Sell Stocks for May 24th
by Zacks Equity Research
ATSG, CCRN and FSFG have been added to the Zacks Rank #5 (Strong Sell) List on May 24, 2023.
New Strong Sell Stocks for May 11th
by Zacks Equity Research
ASLE, BSET and CCRN have been added to the Zacks Rank #5 (Strong Sell) List on May 11, 2023.